WO2010062122A2 - 동맥경화 예방 또는 치료용 조성물 - Google Patents

동맥경화 예방 또는 치료용 조성물 Download PDF

Info

Publication number
WO2010062122A2
WO2010062122A2 PCT/KR2009/007010 KR2009007010W WO2010062122A2 WO 2010062122 A2 WO2010062122 A2 WO 2010062122A2 KR 2009007010 W KR2009007010 W KR 2009007010W WO 2010062122 A2 WO2010062122 A2 WO 2010062122A2
Authority
WO
WIPO (PCT)
Prior art keywords
composition
preventing
artherosclerosis
treating
treating artherosclerosis
Prior art date
Application number
PCT/KR2009/007010
Other languages
English (en)
French (fr)
Other versions
WO2010062122A3 (ko
WO2010062122A9 (ko
Inventor
박찬웅
서대방
전희영
이상민
김완기
이상준
김영명
김춘기
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to JP2011538548A priority Critical patent/JP5635527B2/ja
Priority to US13/131,007 priority patent/US8652542B2/en
Priority to CN2009801553470A priority patent/CN102292091A/zh
Priority to EP09829329.3A priority patent/EP2368559B1/en
Publication of WO2010062122A2 publication Critical patent/WO2010062122A2/ko
Publication of WO2010062122A9 publication Critical patent/WO2010062122A9/ko
Publication of WO2010062122A3 publication Critical patent/WO2010062122A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명에 따른 조성물은 인삼(Panax ginseng C.A. Meyer) 열매의 추출물을 유효성분으로 함유하는 동맥경화 예방 또는 치료용 조성물로서, 상기 인삼 열매 추 출물은 동맥경화로 인한 병변 또는 혈관염증 인자의 생성을 효과적으로 억제할 수 있음을 확인하였는 바, 동맥경화의 예방 또는 치료용 조성물의 유효 성분으로 사용 되기에 적합하다.
PCT/KR2009/007010 2008-11-28 2009-11-26 동맥경화 예방 또는 치료용 조성물 WO2010062122A2 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2011538548A JP5635527B2 (ja) 2008-11-28 2009-11-26 動脈硬化の予防又は治療用組成物
US13/131,007 US8652542B2 (en) 2008-11-28 2009-11-26 Composition for preventing or treating arteriosclerosis
CN2009801553470A CN102292091A (zh) 2008-11-28 2009-11-26 用于预防和治疗动脉硬化的组合物
EP09829329.3A EP2368559B1 (en) 2008-11-28 2009-11-26 Composition for preventing or treating artherosclerosis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080119781A KR101614110B1 (ko) 2008-11-28 2008-11-28 동맥경화 예방 또는 치료용 조성물
KR10-2008-0119781 2008-11-28

Publications (3)

Publication Number Publication Date
WO2010062122A2 true WO2010062122A2 (ko) 2010-06-03
WO2010062122A9 WO2010062122A9 (ko) 2010-09-02
WO2010062122A3 WO2010062122A3 (ko) 2010-10-21

Family

ID=42226260

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/007010 WO2010062122A2 (ko) 2008-11-28 2009-11-26 동맥경화 예방 또는 치료용 조성물

Country Status (6)

Country Link
US (1) US8652542B2 (ko)
EP (1) EP2368559B1 (ko)
JP (2) JP5635527B2 (ko)
KR (1) KR101614110B1 (ko)
CN (2) CN102292091A (ko)
WO (1) WO2010062122A2 (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015501318A (ja) * 2011-10-27 2015-01-15 株式会社アモーレパシフィックＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ シリンガレシノールを含む血管老化抑制用組成物
CN106109474A (zh) * 2016-07-27 2016-11-16 陕西巨子生物技术有限公司 原人参三醇ppt在制备防治血管新生疾病药物中的用途

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102249706B1 (ko) * 2013-04-03 2021-05-10 (주)아모레퍼시픽 인삼열매 추출물을 포함하는 수명 연장용 조성물
KR102262306B1 (ko) * 2013-07-04 2021-06-09 (주)아모레퍼시픽 월경 전기 증후군 및 월경통 완화의 기능을 갖는 조성물
KR101721729B1 (ko) * 2014-05-19 2017-04-10 주식회사 알파벳 진생베리를 이용한 반려동물 사료의 제조방법 및 그에 의해 제조된 반려동물 사료
CN106344586B (zh) * 2016-07-27 2020-02-07 陕西巨子生物技术有限公司 原人参三醇在制备防治毛细血管扩张症药物中的用途
CN113264973A (zh) * 2020-02-17 2021-08-17 厦门大学 一种化合物及其类似物作为RORγ调节剂的应用
KR102327079B1 (ko) * 2021-01-18 2021-11-16 주식회사 파미니티 인삼 추출물을 포함하는 근육 분화 촉진 및 근육 손상 예방용 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH661443A5 (en) 1984-11-22 1987-07-31 Seuref Ag Pharmaceutical compositions having metabolic activity
JPH07267977A (ja) * 1994-03-31 1995-10-17 I T Bi S:Kk オタネ人参の果実エキスよりなる配糖体及びその製造方法並びにこれを用いた健康食品とその製造方法
JPH1070A (ja) * 1996-06-13 1998-01-06 Arusoa Oushiyou:Kk 美容・健康に有用な加工食品
US6007824A (en) 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
CN1092203C (zh) 1998-07-22 2002-10-09 北京鑫利恒医药科技发展有限公司 人参皂甙Re的提取工艺及其新的药物用途
JP2000212080A (ja) 1999-01-26 2000-08-02 Hiroshi Azuma 勃起機能不全改善剤
US6524626B2 (en) 1999-04-23 2003-02-25 E Excel International, Inc. Ginseng berry topical products
MY124001A (en) 1999-04-23 2006-06-30 E Excel Int Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice
US6444237B1 (en) 2001-09-13 2002-09-03 Pamela A. Heleen Herbal composition for enhancing sexual response
CN1440691A (zh) 2002-12-19 2003-09-10 钟惠伦 一种人参果露饮品及其制备方法
AU2003252564A1 (en) 2003-08-18 2005-03-07 Yuyu Inc. A ginseng preparation using vinegar and process for thereof
JP4272100B2 (ja) 2004-04-01 2009-06-03 ポーラ化成工業株式会社 くすみを改善する化粧料
CN100443497C (zh) 2004-04-27 2008-12-17 吉林省宏久生物科技股份有限公司 人参果甙提取方法
CN1628683A (zh) 2004-08-30 2005-06-22 湖南恒伟药业有限公司 治疗脑动脉硬化的血络通制剂
US7884195B2 (en) 2005-04-26 2011-02-08 Long Yun Li Method of extracting ginsengnoside Rg2m, pharmaceutical composition including ginsengnoside Rg2, and uses thereof
KR100802149B1 (ko) 2005-09-16 2008-02-11 주식회사 진생사이언스 혈관 손상에 의한 질환 예방 및 치료용 조성물
CN100584855C (zh) 2005-11-01 2010-01-27 中山以诺生物科技有限公司 采用氧和过氧化物协同氧化碱解三七总皂甙制备原人参二醇和原人参三醇的方法
US20080267938A1 (en) * 2006-09-13 2008-10-30 Jose Angel Olalde Rangel Cardiac phyto-nutraceutical synergistic composition
US20080113043A1 (en) * 2006-10-18 2008-05-15 In-Hwan Seong Method for producing ginseng fruit and ginseng flower stalk with high content of ginsenoside
KR100780056B1 (ko) 2007-04-06 2007-11-29 고붕경 인삼 사포닌 Rg2의 추출방법 및 그 추출물을 포함하는 의약조성물과 그 용도
KR100823940B1 (ko) * 2007-10-26 2008-04-22 (주)청구바이오 인삼 열매를 이용한 식품과 그 제조방법
TWI499645B (zh) 2009-12-25 2015-09-11 Sumitomo Chemical Co Pyridone compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None
See also references of EP2368559A4

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015501318A (ja) * 2011-10-27 2015-01-15 株式会社アモーレパシフィックＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ シリンガレシノールを含む血管老化抑制用組成物
CN106109474A (zh) * 2016-07-27 2016-11-16 陕西巨子生物技术有限公司 原人参三醇ppt在制备防治血管新生疾病药物中的用途

Also Published As

Publication number Publication date
JP6016852B2 (ja) 2016-10-26
KR101614110B1 (ko) 2016-04-21
JP5635527B2 (ja) 2014-12-03
CN105168278A (zh) 2015-12-23
JP2014221803A (ja) 2014-11-27
JP2012509934A (ja) 2012-04-26
EP2368559A2 (en) 2011-09-28
KR20100060962A (ko) 2010-06-07
WO2010062122A3 (ko) 2010-10-21
US20110268824A1 (en) 2011-11-03
EP2368559B1 (en) 2014-08-13
US8652542B2 (en) 2014-02-18
WO2010062122A9 (ko) 2010-09-02
CN105168278B (zh) 2019-01-29
CN102292091A (zh) 2011-12-21
EP2368559A4 (en) 2013-02-27

Similar Documents

Publication Publication Date Title
WO2010062122A3 (ko) 동맥경화 예방 또는 치료용 조성물
WO2009125964A3 (en) Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases
WO2013039365A3 (ko) 지소화성 성분을 함유하는 당뇨 개선용 감미 소재 조성물
WO2013027984A3 (ko) 녹차 성분을 함유하는 화장료 조성물
WO2011073279A3 (fr) Procédé de traitement cosmétique impliquant un composé apte à condenser in situ
WO2010033977A3 (en) Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
WO2007121352A3 (en) Therapeutic triterpenoids
WO2010092088A3 (de) Verwendung von hydrophobin als spreitmittel
WO2011095882A8 (en) Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
WO2012002782A3 (ko) 닥나무의 꽃과 열매 추출물을 함유하는 피부 미백용 피부 외용제 조성물
WO2013092973A3 (en) Composition for treating skin pigmentation
WO2011122872A3 (ko) 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물 포함 조성물
WO2009090394A3 (en) Composition containing capsicum for treating a skin disorder
WO2012161497A3 (ko) 보습능이 우수한 펩타이드 유도체 및 이의 용도
WO2012104240A3 (de) Kosmetische verwendung
WO2011149301A3 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
WO2011001111A3 (fr) Utilisation d'un composé d'acide jasmonique pour traiter la peau grasse
WO2009027382A3 (de) Sprühfähige zusammensetzung enthaltend extrakt aus rotem weinlaub
WO2009156675A3 (fr) Nouvelles compositions dépigmentantes sous forme d'une composition anhydre sans vaseline et sans élastomère comprenant un dérivé phénolique solubilisé et un rétinoïde
WO2013100718A3 (ko) 라저스트로에미아 오바리폴리아 추출물 또는 이의 분획물을 유효성분으로 포함하는 염증성 질환 또는 천식의 예방 또는 치료용 약학적 조성물
EP2384741A3 (en) Topical product
WO2010134769A3 (ko) 과민성 장 증후군의 예방 또는 치료용 조성물
WO2010027221A3 (ko) 비목나무 유래 추출물, 분획물 또는 화합물을 함유하는 피부 미백용 조성물
WO2010051138A3 (en) Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof
BR112013033169A8 (pt) composição que compreende um primeiro extrato de cebola (a) e lipossomas, método para a preparação de uma composição.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980155347.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09829329

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 13131007

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2011538548

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009829329

Country of ref document: EP